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A B S T R A C T
The purpose of the study was to evaluate the efficacy of multilayer amniotic trans-
plantation (AMT) for reconstruction of corneal stroma and epithelium. Corneal ulcer
(28) was a consequence of a previous infectious or neurotrophic keratitis. In the first
group (17) ulcer was covered with monolayer AM, while in the other group (11) there
were two or more layers of AM situated in the ulcer and the whole cornea was covered
with AM sheet. Monolayer AMT was successful in 64% while the multilayer AMT suc-
cess rate was 72%. AM gradually dissolved within 3–6 postoperative weeks. AM trans-
plantation facilitates rapid healing of corneal epithelium, reduces inflammation and
stimulates epithelial cell regrowth. In eyes with deep corneal ulcer multilayer technique
proved to be better then monolayer procedure.
Introduction
Normal ocular surface is covered by
corneal and conjunctival epithelium. Cor-
neal epithelium is well known for its ra-
pid self-renewal process. When normal
healing of corneal epithelial defects is
prevented, unique pathological state is
manifested by poor epithelialization (per-
sistent defects or recurrent erosions),
chronic stromal inflammation (keratitis
accompanied by scarring), corneal vas-
cularization and conjunctival epithelial
ingrowth onto the corneal surface1,2. Nu-
merous factors can cause these condi-
tions, such as malfunction of lids and tear
film, damage of corneal nerves, physical
or chemical injuries, infections, systemic
disorders2,3, as well as disorders that can
cause scarring of the conjunctiva or per-
sistent ocular irritation, primarily or sec-
ondary, involving the cornea4. If severe,
disturbances of the ocular surface may
lead to a significant visual impairment.
It’s been also shown that resident corneal
cells when stimulated can produce spe-
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cial proteins called chemokines that can
lead to the recruitment of inflammatory
cells into the tissue. It has been recog-
nized that stromal keratocytes can tran-
scribe and translate several chemokines,
such as interleukin-8, RANTES, and
MCP-15,6. Moreover, collagenases produ-
ced by keratocytes and polymorphonu-
clears cause progressive corneal thinning
with potential risk of corneal perforation
and loss of the eye. Treatment of such pa-
tients is challenging, often unsatisfactory
and requires combining approach.
Many treatments are used to treat
these conditions. Some of them, such as
padding with lubrication ointment and
artificial tears are in general use. Con-
ventional treatment of such diseases is
aimed to eliminate the underlying dis-
ease mechanism as well as to control in-
flammation and to protect corneal sur-
face. More invasive treatments such as
superficial keratectomy, anterior stromal
puncture or laser (Yag or excimer) ther-
apy have also been used7–10. Recently, nu-
merous papers have been reporting on
the results of the mentioned techniques.
In eyes with phenotypically abnormal
corneal stroma and basal membrane (e.g.
anterior stromal dystrophy, epithelial ba-
sement membrane dystrophy EBMD, ab-
normality of hemidesmosomes and loss of
anchoring fibrils) and in eyes with loss or
hypofunction of the stem cells (limbal de-
ficiency) the conservative treatment will
not be satisfactory8,9. Therefore, these
conditions remain a therapeutic challen-
ge often requiring surgical interven-
tion11,12.
It has been shown that amniotic mem-
brane transplantation on the corneal sur-
face improves healing of epithelium de-
fects by preventing inflammatory cell
infiltration and by reducing apoptosis in
keratocytes. AM is composed of one epi-
thelial cell layer, basement membrane
and avascular stroma. Epithelium pro-
duces basic fibroblast growth factor, he-
patocyte growth factor, and transforming
growth factor . Thick basement mem-
brane serves as an ideal substrate to sup-
port growth of epithelial cells, since it fa-
cilitates migration of epithelial cells, re-
inforces adhesion of basal epithelial cells
and promotes epithelial differentia-
tion14,15. These reactions explain why am-
niotic membrane can be used to facilitate
epithelialization in persistent epithelial
defects. In addition, mentioned charac-
teristics explain why AM can be used to
expand remaining LSC (Limbal Stem
Cells) since it can promote amplification
of cells in cases of partial LSC (limbal
stem cells) deficiency. Moreover, a compo-
nent of corneal epithelial basement mem-
brane collagen IV as well as metallopro-
teinase was identified in the avascular
stroma.
Having in mind the healing properties
of one layer AM in several diseases of ocu-
lar surface16, we wanted to determine
whether its usefulness could be improved
by the use of several layers for recon-
struction of corneal stroma and epithe-
lium in cases of deep stromal ulcers. Also,
we wanted to compare this method with
previously used monolayer technique. In
this paper we compare multilayer and
previously used monolayer technique for
treatment of deep corneal ulcers.
Patients and Methods
Twenty-eight patients with deep stro-
mal ulceration unresponsive to all previ-
ous treatments were included in the
study. Extensive stromal ulcerations per-
sisted for at least several months. Amni-
otic membrane transplantation was per-
formed in a period of 1999–2000. Pre-
ceding diagnosis, age and surgeries are
listed in Table 1. Out of 28 patients 10
had previous infectious ulcer and 18 pa-
tients had neurotrophic keratitis. Pa-
tients were divided into two groups ac-
cording to received treatment, monolayer
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AMT (17) and multilayer AMT (11). All
patients received treatment with artifi-
cial tears, ointment and eye patching
prior to AMT. In two of them punctual
plugs were placed due to the severe ke-
ratitis sicca. In the group with inflamma-
tory keratitis antimicrobial therapy was
administered according to swab finding.
AMT was performed only in cases of neg-
ative control swab. In patients with expo-
sure problems (2 patients in monolayer
group and 1 patient in multilayer group)
AMT was performed after plastic surgery.
In cases of unsuccessful AMT surgery,
second AMT was performed.
Human placenta was obtained in ster-
ile conditions shortly after elective Cae-
sarian section. It was screened against
hepatitis B and C viruses, HIV and syphi-
lis. The method of amniotic membrane
preparation and preservation has been
previously described in our work. Pla-
centa was cleared from blood clots in
standardized »washing solution« contain-
ing antibiotics. The isolated AM was flat-
tened onto the nitroglycerine paper (size
3  3) with the epithelium/basement
membrane side up and stored at –80 °C in
the sterile bottles containing tissue cul-
ture (Inosol, Opsia, France) and glycerol
at the ratio 1:116.
All patients received parabulbar anes-
thesia (2 ml of 2 lidocaine) previous to
surgical procedure. All debris, inflamed
and fibrovascular tissue, together with
the poorly adherent epithelium near the
lesion, as well as the 1–2 mm zone
around the edges of the ulcer were re-
moved using Satin Crescent knife in or-
der to create the firm base for attachment
of the amniotic membrane and to allow
re-epithelialization of the membrane
from a neighboring healthy corneal epi-
thelium. In the monolayer procedure AM
was removed from the storage medium
and transferred to the recipient eye.
Edges were trimmed and one layer of AM
was transferred to the eye with the base-
ment membrane side facing up. The
whole cornea and limbus were covered
and the membrane was sutured onto the
conjunctiva using 10.0 nylon or Vycril su-
tures. Monolayer AM was not sutured to
the cornea to prevent immunological re-
action and vascularization of the cornea.
In the multilayer procedure, first a large
piece of AM was sutured to the upper 2/3
of the conjunctiva covering the whole cor-
nea, then the stromal defect was filled
with up to three layers of AM. If the lay-
ers were stable, sutures were not placed
into the cornea. In cases of mobile mul-
tilayers, the most upper layer was se-
cured to the cornea with interrupted 10–0
nylon sutures. Minimal number of su-
tures able to hold AM in place was used.
After the cavity of the ulcer was filled and
good adherence of the layers was secured,
superficial layer of AM was sutured in
the remaining 1/3 of the circumference to
the conjunctiva with 10–0 nylon sutures.
Postoperatively eyes were bandaged for
two days and antibiotic and solutions
were applied.
Results
The decision for the AMT was made
according to medical indications, after
the failure of other conservative or surgi-
cal procedures.
In eyes where treatment with artifi-
cial tears and ointment was unsuccessful
additional surgical procedures were per-
formed: plastic surgery of the lids, in or-
der to prevent lagophthalmos or trichia-
sis (2 patients from the monolayer group
and 1 patient from the multilayer group)
(Table 1), punctual plugs, in order to en-
able wettable conjunctival and corneal
surface (1 patient from the monolayer
group). Before AM transplantation all pa-
tients with infectious ulcers were treated
with antibiotic therapy till the causing
agent was eradicated.
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The same surgeon performed all surgi-
cal procedures. Out of 28 patients, 17
eyes received monolayer AMT and 11 pa-
tients multilayer AMT. The eyes were ex-
amined every day in the first 4–5 days
and once a week thereafter. Obtained
surgical results are listed in Table 2.
In the group of monolayer procedure
AMT was successful in 10 (64), out of 17
patients. In 6 eyes (60) ulcer has healed
after first transplantation, while in 4 pa-
tients (40%) second transplantation was
necessary. In multilayer procedure group,
transplantation was successful in 8 (72%)
out of 11 patients after the first surgery,
while in 2 cases it had to be repeated.
These results implicate better effective-
ness of multilayer technique as compared
to the monolayer technique.
In spite of the improved overall eye
condition the majority of patients in both
groups retained the same BCVA. In the
monolayer group BCVA of # 0.3 was re-
corded in 4 eyes (23) before transplan-
tation and in 6 eyes (35) after trans-
plantation. In the multilayer group the
same BCVA was recorded in 2 eyes (18%)
before transplantation and in 4 eyes
(36%) after transplantation. Visual im-
provement after surgery did not differ be-
tween the two groups. The results are
listed in Table 3.
Discussion
Amniotic membrane in the eye was
primarily used as an alternative allograft
to replace the lack of conjunctiva in cases
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TABLE 1









NK (10) 20–80 PL (2)
Multilayer 11
NK (3)
PIU (8) 26–75 PL (1)
PIU – Postinfective ulceration, NK – Neurotrophic keratitis, PL – Plastic surgery
TABLE 2







Monolayer 11 / 64% 4–6 7 / 63%
Multilayer 8 / 72% 3–4 6 / 75%
TABLE 3
VISUAL OUTCOME AFTER AMT




Monolayer 4 / 23% 6 / 35%
Multilayer 2 / 18% 4 / 36%
BCVA – Best Corrected Visual Acuity
of surgically created large conjunctival
defects (dysplasia, scars, tumors, and
symblepharon)25. Impression cytology
has proved that few weeks after AMT epi-
thelial phenotype covering AM is con-
junctival, with significantly higher den-
sity of epithelial and goblet cells as
compared to conjunctival tissue trans-
plantation18. These results were attrib-
uted to the unique, but at that time still
unknown, composition of AM17. Recently,
several components and possible mecha-
nisms of action of AM have been recog-
nized. Basement side of the membrane
has proved to be an ideal substrate for ep-
ithelial progenitor cells. It prolongs their
life span and maintains their clonoge-
nicity. Another characteristic of amniotic
membrane is that it promotes non-goblet
differentiation of the conjunctival epithe-
lium18. Eyes with persistent ulceration
are exposed to pathological conditions for
longer period of time and stem cells are
usually partly or totally destroyed19–21.
Therefore, the ability of AM to enhance
growth of progenitor cells might over-
come the lack of stem cells.
Some other ocular disturbances like
peripheral ulcerative and inflammatory
keratitis, limbitis or neurotrophic and
ischemic keratitis do not directly destroy
limbal stem cells, but instead damage the
limbal stroma so that it cannot support
growth of the stem cells21. For partial
limbal deficiency with superficial involve-
ment, amniotic membrane transplanta-
tion can support growth of the cells by re-
ducing the vascularization and preparing
the stroma for epithelial regrowth. AMT
for epithelium regrowths has been advo-
cated by some authors as a sufficient and
even superior to allograft limbal trans-
plantation (ALT) because it does not re-
quire administration of cyclosporin. In
cases of total limbal deficiency, additional
ALT is needed. It has been shown that
AMT enhances successful engraftment of
ALT by preparing the perilimbal stroma
and reducing inflammation and vascu-
larization22–24.
Although most surgeons suture mo-
nolayer AM to the cornea, we have used
monolayer without suturing to the cor-
nea, but instead covering the whole cor-
nea. In this manner the effect of the base-
ment membrane as a replacement for the
damaged Bowman’s membrane was mini-
mized, but the distinctive properties of
the AM stroma were preserved. It was
recognized in several studies that stro-
mal matrix contains specific compounds
that can suppress TGF-beta (Transfor-
ming Growth Factor) signaling, prolifera-
tion and myofibroblast differentiation of
normal corneal and limbal fibroblasts25.
This explains why AMT reduces scarring
during conjunctival surface surgeries.
Such an action is more potent when fi-
broblasts are in contact with the stromal
matrix, and weaker when fibroblasts are
distant from the membrane. This effect
implies that some diffusible factors might
also be secreted by stromal matrix, and
some of them were identified as growth
factors. Moreover, stromal matrix con-
taining various forms of protease inhibi-
tors can decrease inflammatory cell po-
pulation5,25. The unique composition of
AM seams in fact to work as a natural
»healing patch« for corneal ulcers26,27.
The use of multilayer AM can reinforce
the healing effect of AM by amplifying
the concentration of useful factors secre-
ted from the stroma.
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USPOREDBA USPJE[NOSTI TRANSPLANTACIJE VI[ESLOJNE I
JEDNOSLOJNE AMNIJSKE MEMBRANE U LIJE^ENJU DUBOKIH
ULKUSA
S A @ E T A K
Cilj rada bio je ustanoviti je li transplantacije vi{eslojne amnijske membrane pri-
likom lije~enja dubokih ulkusa ro`nice u~inkovitija od jednostruke transplantacije.
Ro`ni~ni ulkus (28) nastao je kao posljedica recidiviraju}ih infekcija ili neurotrofi~kih
keratitisa. U prvoj grupi ispitanika (17) ro`nica je bila pokrivena jednostrukom amnij-
skom membranom, dok su u drugoj skupini (11) presa|ena dva ili vi{e slojeva AM u
sam defekt, a cijela je ro`nica bila dodatno pokrivena jednim slojem amnija. Membra-
na se postupno rastopila unutar 3–6 postoperativnih tjedana. Jednostruka transplan-
tacija bila je uspje{na u 64% slu~ajeva, dok je nakon presa|ivanja vi{e slojeva do iz-
lje~enja do{lo u 72% ispitanika. Istra`ivanje je pokazalo da je u lije~enju dubokih
ulkusa ro`nice uspje{nija metoda presa|ivanja vi{eslojne amnijske membrane.
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